Medications as a potential source of exposure to phthalates in the U.S. population - Wikidata - awgldk - TriplyDB

Medications as a potential source of exposure to phthalates in the U.S. population

Medications as a potential source of exposure to phthalates in the U.S. population

http://www.wikidata.org/entity/Q23921497

about

Teratogenic mechanisms of medical drugs Estimated daily intake of phthalates in occupationally exposed groups Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management Reproductive and developmental effects of phthalate diesters in females Management of inflammatory bowel disease in pregnancy Prenatal phthalate exposures and neurobehavioral development scores in boys and girls at 6-10 years of age Prenatal exposure to phthalate esters and behavioral syndromes in children at 8 years of age: Taiwan Maternal and Infant Cohort Study The kynurenine pathway activities in a sub-Saharan HIV/AIDS population Medications as a potential source of exposure to phthalates among women of childbearing age The effects of phthalates on the ovary Phthalate exposure and children's health Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review Consumer product exposures associated with urinary phthalate levels in pregnant women Predictors and long-term reproducibility of urinary phthalate metabolites in middle-aged men and women living in urban Shanghai Mechanisms mediating environmental chemical-induced endocrine disruption in the adrenal gland A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and semen quality in men with inflammatory bowel disease Phthalate exposure and allergy in the U.S. population: results from NHANES 2005-2006 Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's disease Presence of phthalates in gastrointestinal medications: is there a hidden danger?The association of socio-demographic status, lifestyle factors and dietary patterns with total urinary phthalates in Australian men The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001-2010 Pregnancy and Inflammatory Bowel Disease Di-n-butyl phthalate disrupts the expression of genes involved in cell cycle and apoptotic pathways in mouse ovarian antral follicles Prenatal exposure to phthalates and infant development at 6 months: prospective Mothers and Children's Environmental Health (MOCEH) study The effects of di(2-ethylhexyl)phthalate on rat liver in relation to selenium status Prenatal exposure to di-(2-ethylhexyl) phthalate (DEHP) affects reproductive outcomes in female mice Short term exposure to di-n-butyl phthalate (DBP) disrupts ovarian function in young CD-1 mice.Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999-2004 Identification of phthalates in medications and dietary supplement formulations in the United States and Canada Urinary phthalate metabolite concentrations among men with inflammatory bowel disease on mesalamine therapy Associations between bone mineral density and urinary phthalate metabolites among post-menopausal women: a cross-sectional study of NHANES data 2005-2010.Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.Assessing exposure to phthalates - the human biomonitoring approach.Pregnancy and breastfeeding in inflammatory bowel disease.Xenobiotic effects in the ovary: temporary versus permanent infertility.Inflammatory bowel disease in women of reproductive age.A review of selected chemical additives in cosmetic products.Methods for the Determination of Endocrine-Disrupting Phthalate Esters.Management of Inflammatory Bowel Disease During Pregnancy.Population Exposure to Phthalate-containing Drugs.

P2860

Q22337136-078908E6-0E07-4C8C-945F-738ED81BEE42 Q23911337-6605B3E6-1C6A-487C-AF90-B4BAC1DBF5C2 Q26777627-B2409374-B906-4332-9DF6-74827D13476F Q26864701-633CF9C3-478F-4B62-8683-230B965DA3C8 Q26865914-56B5D1CC-6F83-401C-9647-C2FD95470792 Q28385477-33E78AB8-09BD-4C63-87C8-632A9ACA0C5C Q28385500-7673E3A0-23A4-45BA-AC8D-56AA7F1E7687 Q28386378-9CBDDBEE-CC98-4ED1-876D-42F94494351E Q28386604-66ABF556-66D1-4BA1-BBCB-3E503B37DD7B Q28387140-43CC6CD6-897C-41CE-94F9-480479F11569 Q28387495-172A0E76-D503-4816-AD5C-C071B5A2F820 Q28388274-25363FED-69B0-4540-B176-15DC5F71E325 Q28388462-45135377-F94E-4DF6-A27F-19F970063F20 Q28388756-D2E3ABC6-A10F-49BC-A49D-6C9F1B203F35 Q28389245-D86F522A-3FC4-42BC-A293-DC80ED1D7CB1 Q28389648-F2489D45-E240-4350-AF76-DD2173C02C9C Q28389981-C760A9B2-A03C-4636-8645-E05EF64C682C Q28390019-FD6327F0-B5E3-4CC2-92A5-015A85F2E339 Q28390661-FF060522-4BB7-4638-AF2A-AFF93F4A0558 Q28391859-43570CCE-7FB6-46DB-A83E-EA379A0C86D7 Q28392243-FEC682EC-F70A-4760-B9C8-465BC2A47061 Q28392552-8DADEBAC-DD9A-4128-B4B9-CAFCAC3B0515 Q28394314-F60C6F7A-394F-4620-9E52-B2D169860596 Q28394467-04DFDAF4-E927-4088-AAB9-64E0E6224D32 Q28395705-EB3818A5-BBEB-4C16-965B-B2E220FFB9C0 Q28395788-1C70B44D-17B2-438E-8CAE-2A6DB31F545C Q28395798-76774470-2F26-4D7F-90B5-0F9A4A3A2D2C Q28396781-F32C243D-135B-4718-A707-43363D7F65BD Q28397343-D8BBAD93-EF11-415D-B1CD-7452325A997C Q28397446-E609CCA0-D191-4E85-8AC9-18B77311811C Q31026737-D414759A-2334-46AC-B182-A596C238E84E Q34244877-C38851CD-5318-4EED-B0A1-6EF8C36AD6FF Q37766561-586009F6-A3A6-464E-B25C-D202F2B162C8 Q38050886-FC7A6C74-A1BE-4EF4-BD27-03B0CEBE3D5B Q38180818-4461B2C8-BD99-4B4E-838A-F6F5CF07560B Q38192051-10F5CC1C-1DFF-4FE6-8284-1189C0830872 Q38232839-3C9F8316-FD6C-46A9-A15E-BE62E84EAC9C Q38399717-A17880AD-5F33-4F24-9D45-0B3E46CCA426 Q38805484-B988E1FE-1B5A-4025-A8F0-6C879A39B408 Q38858862-FA107755-AED8-4CD3-B26E-CF44DE69147B

P2860

Medications as a potential source of exposure to phthalates in the U.S. population

http://www.wikidata.org/entity/Q23921497

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Medications as a potential source of exposure to phthalates in the U.S. population

@ast

Medications as a potential source of exposure to phthalates in the U.S. population

@en

Medications as a potential source of exposure to phthalates in the U.S. population

@en-gb

Medications as a potential source of exposure to phthalates in the U.S. population

@nl

type

label

Medications as a potential source of exposure to phthalates in the U.S. population

@ast

Medications as a potential source of exposure to phthalates in the U.S. population

@en

Medications as a potential source of exposure to phthalates in the U.S. population

@en-gb

Medications as a potential source of exposure to phthalates in the U.S. population

@nl

prefLabel

Medications as a potential source of exposure to phthalates in the U.S. population

@ast

Medications as a potential source of exposure to phthalates in the U.S. population

@en

Medications as a potential source of exposure to phthalates in the U.S. population

@en-gb

Medications as a potential source of exposure to phthalates in the U.S. population

@nl

P1433

Q23921497-60FA2281-FA21-4D27-AA4B-29EE99919A7D

P1476

Q23921497-F5154107-ED6C-49F1-9D0B-9D92364B5822

P2093

Q23921497-2402AC76-987D-4AA7-BB0A-556D880C46E7

Q23921497-3EFF225C-D45E-45BD-A78D-6A0C35A5511D

Q23921497-ADE7D626-7B23-4C8A-AD46-E155EBEB7E73

P2860

Q23921497-2EC26228-EE48-437B-BF27-516D956587F5

Q23921497-41F5D56E-DE93-4429-86CA-18A6C92C2B48

Q23921497-4A4D3D73-D6A3-4CD5-BE25-F429F2739259

Q23921497-4ACC74D2-392A-4177-B56A-268B149A5089

Q23921497-51FCD854-C806-46D6-BA4E-86A36661DE41

Q23921497-581B5EF0-3D80-47E3-9ADA-847566996F8C

Q23921497-6EDCCBB4-54C8-48C6-A7DF-B30165D9B734

Q23921497-70EC23E9-4B04-44B7-ABCA-E9569FD4C594

Q23921497-7FD35ABA-41F1-4A32-BB01-0175D0D83911

Q23921497-8727DAF8-609C-4101-9A49-2DE648ECF435

P2880

Q23921497-BF2050CC-F41C-4BE8-97A2-55D37133C5FD

P304

Q23921497-E7B137DB-75C1-4792-BE99-4F27224B2479

P31

Q23921497-8C6B4E08-5CEF-476A-8C09-97019EEBF5C9

P3181

Q23921497-8B0400EA-9A47-4A59-9F11-228C4BBA36D9

P356

Q23921497-0250F50D-2D77-4276-886A-F27F852CBFB0

P407

Q23921497-FC1502FA-2B13-47C9-932F-182C788E2EFA

P433

Q23921497-6F80DCFD-609A-4316-AF1D-BA6231DD22DA

P478

Q23921497-3137603D-F7F8-4065-B41C-4BE1F5A2F4D3

P50

Q23921497-0B200E25-0E82-47D2-BD8A-80AFA722D099

Q23921497-F0054CD5-C74D-4AE2-869A-F70842301007

P577

Q23921497-FDA90A21-9521-41A8-B820-4A9A31714D07

P5875

Q23921497-F70B5C48-D90C-4679-9FAE-CA9585DD7CD1

P698

Q23921497-D6D8C5B9-5619-4701-8F82-DF190A4C5FA5

P859

Q23921497-2D2DC973-145B-4263-ABD7-C536D467138A

P921

Q23921497-0A4BBD11-E619-420A-BCB5-5A2441862243

Q23921497-0E43ED1D-8130-4619-BB51-2562548C8C30

Q23921497-5236976C-A40D-443A-BEF4-698F66BAFAF9

Q23921497-67EF5059-D57E-4BBB-9FAB-528F15FA6E38

Q23921497-7626D350-49AE-4920-9B31-AC3F94BB55F5

Q23921497-BCA5A039-F3DA-4700-952C-6292B7E6D594

Q23921497-DB75C77D-16DC-4C8E-B33B-479FD0303A46

P932

Q23921497-DC409888-C1D9-4713-9286-DD4D4B138D8C

P3181

P356

P1433

Environmental Health Perspectives

P1476

Medications as a potential source of exposure to phthalates in the U.S. population

@en

P2093

Allen A Mitchell

http://www.w3.org/2001/XMLSchema#string

Katherine E Kelley

http://www.w3.org/2001/XMLSchema#string

Sonia Hernández-Díaz

http://www.w3.org/2001/XMLSchema#string

P2860

Decrease in anogenital distance among male infants with prenatal phthalate exposure

Exposure to phthalate esters

Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000

Medications as a source of human exposure to phthalates

The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat

Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat.

Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance.

Phthalates and human health

An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population.

Analysis of human urine for fifteen phthalate metabolites using automated solid-phase extraction.

P2880

20035106

http://www.w3.org/2001/XMLSchema#string

P304

185-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2314681

http://www.w3.org/2001/XMLSchema#string

P356

10.1289/EHP.11766

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Antonia M. Calafat

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24186177

http://www.w3.org/2001/XMLSchema#string

P698

19270786

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

reproductive health

biological hazard

P932

2649218

http://www.w3.org/2001/XMLSchema#string